Daewon Pharmaceutical Revenue

Daewon Pharmaceutical had revenue of 156.83B KRW in the quarter ending September 30, 2024, with 21.59% growth. This brings the company's revenue in the last twelve months to 593.94B, up 16.77% year-over-year. In the year 2023, Daewon Pharmaceutical had annual revenue of 526.95B with 10.04% growth.

Revenue (ttm)

593.94B

Revenue Growth

+16.77%

P/S Ratio

0.52

Revenue / Employee

471.38M

Employees

1,260

Market Cap

309.93B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	526.95B	48.07B	10.04%
Dec 31, 2022	478.88B	124.71B	35.21%
Dec 31, 2021	354.18B	45.68B	14.81%
Dec 31, 2020	308.50B	-9.33B	-2.93%
Dec 31, 2019	317.83B	31.18B	10.88%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,364.39B
Celltrion	2,876.25B
Yuhan	2,008.84B
SK Biopharmaceuticals	511.33B
SK bioscience	201.30B
Hanmi Pharm.	1,495.50B
Peptron	2.41B
Hanall Biopharma	134.24B

Revenue Rankings